MODERN THERAPY OF CHRONIC HEART FAILURE: IMPORTANCE OF ALDOSTERONE ANTAGONISTS
Keywords:
heart failure, pathogenesis, clinical manifestation, medical treatment
Abstract
The place of aldosterone antagonists in modern therapy of chronic heart failure is considered. It is shown, that the aldosterone antagonists expand influences of angiotensin converting enzyme inhibitors on the renin-aldosterone-angiotensin system, what promotes achievement of more significant steady positive results in medical treatment of patients with heart failure.
Downloads
Download data is not yet available.
References
1. Blacher J., Amah G., Girerd X., et al. // Am J Hypertens. - 1997. - № 10. - Р. 1326-1334.
2. Blasi E.R., Rocha R., Rudolph A.E., et al. // Kidney Int - 2003. - № 63. - Р. 1791-1800.
3. Booth E., Johnson J.P., Stockand J.D. // Adv Physiol Educ. - 2002. - № 26. - Р. 8-20.
4. Brown N.J., Kim K.S., Chen Y.Q., et al. // J Clin Endocrinol Metab. - 2000. - № 85. - Р. 336-344.
5. Degasparo M., Joss U., Ramjoue, et al. // J Pharmacol Exp Ther. - 1987. - № 240. - Р. 650-656.
6. Delyani J., Myles K., Funder J., et al. // Am J Hypertens. - 1998. - № 11- Р. 94A.
7. Duprez D., De Buyzere M., Rietzschel E.R., et al. // Curr Hypertens Rep. - 2000. - № 2. - Р. 327-334.
8. Guidelines for the diagnosis and treatment of Chronic Heart Failure: full text (update 2005): The Task Force for the Diagnosis and Treatment of CHF of the European Society of Cardiology. // Eur Heart J - 2005. doi: 10.1093/eurheartj/ehi205. - Р. 1-45.
9. Krum H., Liew D. // Expert Rev Cardiovasc Ther. - 2004. May. - № 2(3). - Р. 315-320.
10. McFaiden R., Barr C., Struthers A. // Cardiovasc Research. - 1997. - № 35. - Р. 30-34.
11. McMachon E. // N Engl J Med. - 2003. - № 348. - Р. 1309-1321.
12. Pitt B., Roniker B. // J Am Coll Cardiol. – 1999. – № 33. – Р. 188A-189A.
13. Pitt B. et al. // N Engl J Med. - 1999. - № 341. - Р. 709–717.
14. Pitt B. et al. // N Engl J Med. - 2003. - № 348. - Р. 1309-1321.
15. Rajagopalan S., Duquaine D., King S., et al. // Circulation. - 2002. - № 105. - Р. 2212-2226.
16. Randomized ALdactone Evaluation Study. Eur Heart J – 1995. - 16(suppl N). - Р.107-110. N Eng J Med 1999;341:709-717 Seckl JR and Walker BR. Minireview: 11beta-hydroxysteroid dehydrogenase type 1-a tissue-specific amplifier of glucocorticoid action. // Endocrinology. - 2001. - № 142. - Р. 1371-1376.
17. Schunkert H., Hense H.W., Danser J., et al. // Br Heart J. - 1997. - № 77. - Р. 24-31.
18. Spertus A., Tooley Phar J., Jones P., et al. // Am Heart J. - 2002. - № 143. - Р. 636-642.
19. Struthers A.D. // J Renin Angiotensin Aldosterone Syst. - 2004. Sep. - № 5. - Suppl 1. - Р. S23-27.
20. Struthers A.D. // Heart. - 2006. Dec. - № 92(12). - Р. 1728-1731.
21. Weber K.T. // Curr Heart Fail Rep. - 2004. Jul. - № 1(2). - Р. 51-56.
2. Blasi E.R., Rocha R., Rudolph A.E., et al. // Kidney Int - 2003. - № 63. - Р. 1791-1800.
3. Booth E., Johnson J.P., Stockand J.D. // Adv Physiol Educ. - 2002. - № 26. - Р. 8-20.
4. Brown N.J., Kim K.S., Chen Y.Q., et al. // J Clin Endocrinol Metab. - 2000. - № 85. - Р. 336-344.
5. Degasparo M., Joss U., Ramjoue, et al. // J Pharmacol Exp Ther. - 1987. - № 240. - Р. 650-656.
6. Delyani J., Myles K., Funder J., et al. // Am J Hypertens. - 1998. - № 11- Р. 94A.
7. Duprez D., De Buyzere M., Rietzschel E.R., et al. // Curr Hypertens Rep. - 2000. - № 2. - Р. 327-334.
8. Guidelines for the diagnosis and treatment of Chronic Heart Failure: full text (update 2005): The Task Force for the Diagnosis and Treatment of CHF of the European Society of Cardiology. // Eur Heart J - 2005. doi: 10.1093/eurheartj/ehi205. - Р. 1-45.
9. Krum H., Liew D. // Expert Rev Cardiovasc Ther. - 2004. May. - № 2(3). - Р. 315-320.
10. McFaiden R., Barr C., Struthers A. // Cardiovasc Research. - 1997. - № 35. - Р. 30-34.
11. McMachon E. // N Engl J Med. - 2003. - № 348. - Р. 1309-1321.
12. Pitt B., Roniker B. // J Am Coll Cardiol. – 1999. – № 33. – Р. 188A-189A.
13. Pitt B. et al. // N Engl J Med. - 1999. - № 341. - Р. 709–717.
14. Pitt B. et al. // N Engl J Med. - 2003. - № 348. - Р. 1309-1321.
15. Rajagopalan S., Duquaine D., King S., et al. // Circulation. - 2002. - № 105. - Р. 2212-2226.
16. Randomized ALdactone Evaluation Study. Eur Heart J – 1995. - 16(suppl N). - Р.107-110. N Eng J Med 1999;341:709-717 Seckl JR and Walker BR. Minireview: 11beta-hydroxysteroid dehydrogenase type 1-a tissue-specific amplifier of glucocorticoid action. // Endocrinology. - 2001. - № 142. - Р. 1371-1376.
17. Schunkert H., Hense H.W., Danser J., et al. // Br Heart J. - 1997. - № 77. - Р. 24-31.
18. Spertus A., Tooley Phar J., Jones P., et al. // Am Heart J. - 2002. - № 143. - Р. 636-642.
19. Struthers A.D. // J Renin Angiotensin Aldosterone Syst. - 2004. Sep. - № 5. - Suppl 1. - Р. S23-27.
20. Struthers A.D. // Heart. - 2006. Dec. - № 92(12). - Р. 1728-1731.
21. Weber K.T. // Curr Heart Fail Rep. - 2004. Jul. - № 1(2). - Р. 51-56.
How to Cite
YabluchanskіyN. (1). MODERN THERAPY OF CHRONIC HEART FAILURE: IMPORTANCE OF ALDOSTERONE ANTAGONISTS. The Journal of V. N. Karazin Kharkiv National University, Series "Medicine", (14), 136-140. Retrieved from https://periodicals.karazin.ua/medicine/article/view/7054
Issue
Section
Lectures
The Journal of V. N. Karazin Kharkiv National University, series Medicine has following copyright terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work’s authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal’s published version of the work, with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
